Specify a stock or a cryptocurrency in the search bar to get a summary
Eterna Therapeutics Inc
ERNAEterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts. Address: 1035 Cambridge Street, Cambridge, MA, United States, 02141
Analytics
WallStreet Target Price
3 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ERNA
Dividend Analytics ERNA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ERNA
Stock Valuation ERNA
Financials ERNA
Results | 2019 | Dynamics |